Delta-Fly Pharma

About:

Delta-Fly Pharma is a pharmaceutical company developing innovative cancer treatments through a unique module drug discovery approach

Website: https://www.delta-flypharma.co.jp/

Twitter/X: fly_pharma

Top Investors: SMBC Venture Capital, Mitsubishi UFJ Capital, Mizuho Capital, Nissay Capital, Nippon Venture Capital

Description:

Their company name "Delta-Fly" is derived from "Dragonfly (Tonbo)". Tonbo symbolizes the spirit of "regression" from where it only retreats forward, and is also called "the winning insect."

Total Funding Amount:

1.88B JPY

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Tokushima-shi, Tokushima, Japan

Founded Date:

2010-12-06

Founders:

Atsushi Ejima

Number of Employees:

11-50

Last Funding Date:

2018-03-23

IPO Status:

Public

Industries:

© 2025 bioDAO.ai